46 research outputs found
Penentuan Rating Review Film Menggunakan Metode Multinomial NaĂŻve Bayes Classifier dengan Feature Selection Berbasis Chi-Square dan Galavotti-Sebastiani-Simi Coefficient
Pada era saat ini terdapat berbagai ragam film, meskipun cara
pendekatannya berbeda-beda, semua film dapat dikatakan mempunyai satu
sasaran, yaitu menarik perhatian orang terhadap muatan-muatan masalah yang
dikandung. Dari muatan-muatan film tersebut terdapat banyak respons dari
penulis dan menuliskannya dalam review singkatnya. Dengan adanya review bisa
membantu penonton untuk lebih selektif lagi dalam memilih suatu film. Dan dari
pihak produksi bisa terbantu untuk mengukur seberapa jauh kualitas film yang
mereka hasilkan. Namun dari pihak produksi sendiri terkadang mengalami
kesulitan dalam memilah dan mengkategorikan review, apakah produk tersebut
kualitasnya tergolong bagus, cukup bagus, tidak bagus, dan sebagainya. Dalam
penelitian ini peniliaian suatu film berdasarkan review yang diberikan adalah
Rating. Sehingga dibutuhkan sebuah sistem prediksi Rating untuk memprediksi
dan menentukan Rating yang tepat berdasarkan review yang diberikan oleh
pengguna terhadap suatu film. Untuk mendukung sistem yang dibangun
dibutuhkan metode untuk menyelesaikan permasalahan tersebut, dalam
penelitian ini peneliti menggunakan Metode Multinomial NaĂŻve Bayes serta Chi-
Square dan Galavotti-Sebastiani-Simi Coefficient. Multinomial NaĂŻve Bayes
adalah metode untuk klasifikasi sedangkan Chi-Square dan Galavotti-Sebastiani-
Simi Coefficient adalah feature selection untuk lebih mengoptimalkan hasil dari
klasifikasi. Dari hasil pengujian, didapat tingkat akurasi terbaik pada saat
penggunaan feature sebesar 90%, dan 100% dengan tingkat akurasi sebesar 36%.
Hasil tersebut adalah hasil terbaik dari hasil dengan prosentase penggunaan
feature yang lain. Dari hasil tersebut CHI-GSS terbukti bisa melakukan pemilihan
kata yang dianggap relevan maupun tidak relevan untuk dilakukan klasifikasi
Reliability of Single-Use PEEP-Valves Attached to Self-Inflating Bags during Manual Ventilation of Neonates â An In Vitro Study
Introduction International resuscitation guidelines suggest to use positive
end-expiratory pressure (PEEP) during manual ventilation of neonates. Aim of
our study was to test the reliability of self-inflating bags (SIB) with
single-use PEEP valves regarding PEEP delivery and the effect of different
peak inflation pressures (PIP) and ventilation rates (VR) on the delivered
PEEP. Methods Ten new single-use PEEP valves from 5 manufacturers were tested
by ventilating an intubated 1kg neonatal manikin containing a lung model with
a SIB that was actuated by an electromechanical plunger device. Standard
settings: PIP 20cmH2O, VR 60/min, flow 8L/min. PEEP settings of 5 and 10cmH2O
were studied. A second test was conducted with settings of PIP 40cmH2O and VR
40/min. The delivered PEEP was measured by a respiratory function monitor
(CO2SMO+). Results Valves from one manufacturer delivered no relevant PEEP and
were excluded. The remaining valves showed a continuous decay of the delivered
pressure during expiration. The median (25th and 75th percentile) delivered
PEEP with standard settings was 3.4(2.7â3.8)cmH2O when set to 5cmH2O and
6.1(4.9â7.1)cmH2O when set to 10cmH2O. Increasing the PIP from 20 to 40 cmH2O
led to a median (25th and 75th percentile) decrease in PEEP to
2.3(1.8â2.7)cmH2O and 4.3(3.2â4.8)cmH2O; changing VR from 60 to 40/min led to
a PEEP decrease to 2.8(2.1â3.3)cmH2O and 5.0(3.5â6.2)cmH2O for both PEEP
settings. Conclusion Single-use PEEP valves do not reliably deliver the set
PEEP. PIP and VR have an effect on the delivered PEEP. Operators should be
aware of these limitations when manually ventilating neonates
Recommended from our members
A randomised controlled trial of early insulin therapy in very low birth weight infants, "NIRTURE" (neonatal insulin replacement therapy in Europe).
BACKGROUND: Studies in adult intensive care have highlighted the importance of insulin and improved glucose control on survival, with 32% reduction in mortality, 22% reduction in intensive care stay and halving of the incidence of bacteraemia. Very low birth weight infants requiring intensive care also have relative insulin deficiency often leading to hyperglycaemia during the first week of life. The physiological influences on insulin secretion and sensitivity, and the potential importance of glucose control at this time are not well established. However there is increasing evidence that the early postnatal period is critical for pancreatic development. At this time a complex set of signals appears to influence pancreatic development and beta cell survival. This has implications both in terms of acute glucose control but also relative insulin deficiency is likely to play a role in poor postnatal growth, which has been associated with later motor and cognitive impairment, and fewer beta cells are linked to risk of type 2 diabetes later in life. METHODS: A multi-centre, randomised controlled trial of early insulin replacement in very low birth weight babies (VLBW, birth weight < 1500 g). 500 infants will be recruited from 10 centres in the UK and Europe. Babies will be randomised to receive a continuous insulin infusion (0.05 units/kg/h) or to receive standard neonatal care from the first day of life and for the next 7 days. If blood glucose (BG) levels fall infants will receive 20% dextrose titrated to maintain normoglycaemia (4-8 mmol/l). If BG is consistently above 10 mmol/l babies will receive standard treatment with additional insulin infusion. The primary end point will be mortality on or before expected date of delivery, secondary end points will be markers of morbidity and include episodes of sepsis, severity of retinopathy, chronic lung disease and growth
Increasing Respiratory Effort With 100% Oxygen During Resuscitation of Preterm Rabbits at Birth
Background: Spontaneous breathing is essential for successful non-invasive respiratory support delivered by a facemask at birth. As hypoxia is a potent inhibitor of spontaneous breathing, initiating respiratory support with a high fraction of inspired O2 may reduce the risk of hypoxia and increase respiratory effort at birth.
Methods: Preterm rabbit kittens (29 days gestation, term ~32 days) were delivered and randomized to receive continuous positive airway pressure with either 21% (n = 12) or 100% O2 (n = 8) via a facemask. If apnea occurred, intermittent positive pressure ventilation (iPPV) was applied with either 21% or 100% O2 in kittens who started in 21% O2, and remained at 100% O2 for kittens who started the experiment in 100% O2. Respiratory rate (breaths per minute, bpm) and variability in inter-breath interval (%) were measured from esophageal pressure recordings and functional residual capacity (FRC) was measured from synchrotron phase-contrast X-ray images.
Results: Initially, kittens receiving 21% O2 had a significantly lower respiratory rate and higher variability in inter-breath interval, indicating a less stable breathing pattern than kittens starting in 100% O2 [median (IQR) respiratory rate: 16 (4â28) vs. 38 (29â46) bpm, p = 0.001; variability in inter-breath interval: 33.3% (17.2â50.1%) vs. 27.5% (18.6â36.3%), p = 0.009]. Apnea that required iPPV, was more frequently observed in kittens in whom resuscitation was started with 21% compared to 100% O2 (11/12 vs. 1/8, p = 0.001). After recovering from apnea, respiratory rate was significantly lower and variability in inter-breath interval was significantly higher in kittens who received iPPV with 21% compared to 100% O2. FRC was not different between study groups at both timepoints.
Conclusion: Initiating resuscitation with 100% O2 resulted in increased respiratory activity and stability, thereby reducing the risk of apnea and need for iPPV after birth. Further studies in human preterm infants are mandatory to confirm the benefit of this approach in terms of oxygenation. In addition, the ability to avoid hyperoxia after initiation of resuscitation with 100% oxygen, using a titration protocol based on oxygen saturation, needs to be clarified
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants <â29 weeksâ gestation
Background: Bronchopulmonary dysplasia (BPD) is a major cause of mortality and long-term respiratory and neurological morbidity in very preterm infants. While survival rates of very preterm infants have increased over the past two decades there has been no decrease in the rate of BPD in surviving infants. Evidence from animal and human studies has suggested potential benefits of docosahexaenoic acid (DHA), an n-3 long chain polyunsaturated fatty acid, in the prevention of chronic lung disease. This randomised controlled trial aims to determine the effectiveness of supplementary DHA in reducing the rate of BPD in infants less than 29 weeksâ gestation.
Methods/design: This is a multicentre, parallel group, randomised, blinded and controlled trial. Infants born less than 29 weeksâ gestation, within 3 days of first enteral feed and with parent informed consent are eligible to participate. Infants will be randomised to receive an enteral emulsion containing DHA or a control emulsion without DHA. The DHA emulsion will provide 60 mg/kg/day of DHA. The study emulsions will continue to 36 weeksâ postmenstrual age (PMA). The primary outcome is BPD as assessed by the requirement for supplemental oxygen and/or assisted ventilation at 36 weeksâ PMA. Secondary outcomes include the composite of death or BPD; duration of respiratory support and hospitalisation, major neonatal morbidities. The target sample size is 1244 infants (622 per group), which will provide 90 % power to detect a clinically meaningful absolute reduction of 10 % in the incidence of BPD between the DHA and control emulsion (two tailed α =0.05).
Discussion: DHA supplementation has the potential to reduce respiratory morbidity in very preterm infants. This multicentre trial will provide evidence on whether an enteral DHA supplement reduces BPD in very preterm infants
Increasing Respiratory Effort With 100% Oxygen During Resuscitation of Preterm Rabbits at Birth
Background: Spontaneous breathing is essential for successful non-invasive respiratory support delivered by a facemask at birth. As hypoxia is a potent inhibitor of spontaneous breathing, initiating respiratory support with a high fraction of inspired O2 may reduce the risk of hypoxia and increase respiratory effort at birth. Methods: Preterm rabbit kittens (29 days gestation, term ~32 days) were delivered and randomized to receive continuous positive airway pressure with either 21% (n = 12) or 100% O2 (n = 8) via a facemask. If apnea occurred, intermittent positive pressure ventilation (iPPV) was applied with either 21% or 100% O2 in kittens who started in 21% O2, and remained at 100% O2 for kittens who started the experiment in 100% O2. Respiratory rate (breaths per minute, bpm) and variability in inter-breath interval (%) were measured from esophageal pressure recordings and functional residual capacity (FRC) was measured from synchrotron phase-contrast X-ray images. Results: Initially, kittens receiving 21% O2 had a significantly lower respiratory rate and higher variability in inter-breath interval, indicating a less stable breathing pattern than kittens starting in 100% O2 [median (IQR) respiratory rate: 16 (4â28) vs. 38 (29â46) bpm, p = 0.001; variability in inter-breath interval: 33.3% (17.2â50.1%) vs. 27.5% (18.6â36.3%), p = 0.009]. Apnea that required iPPV, was more frequently observed in kittens in whom resuscitation was started with 21% compared to 100% O2 (11/12 vs. 1/8, p = 0.001). After recovering from apnea, respiratory rate was significantly lower and variability in inter-breath interval was significantly higher in kittens who received iPPV with 21% compared to 100% O2. FRC was not different between study groups at both timepoints. Conclusion: Initiating resuscitation with 100% O2 resulted in increased respiratory activity and stability, thereby reducing the risk of apnea and need for iPPV after birth. Further studies in human preterm infants are mandatory to confirm the benefit of this approach in terms of oxygenation. In addition, the ability to avoid hyperoxia after initiation of resuscitation with 100% oxygen, using a titration protocol based on oxygen saturation, needs to be clarified
Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants
Studies in animals and in humans have suggested that docosahexaenoic acid (DHA), an n-3 long-chain polyunsaturated fatty acid, might reduce the risk of bronchopulmonary dysplasia, but appropriately designed trials are lacking.We randomly assigned 1273 infants born before 29 weeks of gestation (stratified according to sex, gestational age
The LifeCycle Project-EU Child Cohort Network : a federated analysis infrastructure and harmonized data of more than 250,000 children and parents
Early life is an important window of opportunity to improve health across the full lifecycle. An accumulating body of evidence suggests that exposure to adverse stressors during early life leads to developmental adaptations, which subsequently affect disease risk in later life. Also, geographical, socio-economic, and ethnic differences are related to health inequalities from early life onwards. To address these important public health challenges, many European pregnancy and childhood cohorts have been established over the last 30 years. The enormous wealth of data of these cohorts has led to important new biological insights and important impact for health from early life onwards. The impact of these cohorts and their data could be further increased by combining data from different cohorts. Combining data will lead to the possibility of identifying smaller effect estimates, and the opportunity to better identify risk groups and risk factors leading to disease across the lifecycle across countries. Also, it enables research on better causal understanding and modelling of life course health trajectories. The EU Child Cohort Network, established by the Horizon2020-funded LifeCycle Project, brings together nineteen pregnancy and childhood cohorts, together including more than 250,000 children and their parents. A large set of variables has been harmonised and standardized across these cohorts. The harmonized data are kept within each institution and can be accessed by external researchers through a shared federated data analysis platform using the R-based platform DataSHIELD, which takes relevant national and international data regulations into account. The EU Child Cohort Network has an open character. All protocols for data harmonization and setting up the data analysis platform are available online. The EU Child Cohort Network creates great opportunities for researchers to use data from different cohorts, during and beyond the LifeCycle Project duration. It also provides a novel model for collaborative research in large research infrastructures with individual-level data. The LifeCycle Project will translate results from research using the EU Child Cohort Network into recommendations for targeted prevention strategies to improve health trajectories for current and future generations by optimizing their earliest phases of life.Peer reviewe